Hopes that the end of the pandemic has become nearer have soared after the news that a coronavirus vaccine was found to be 90 % effective in global trials . 
Although there is definite reason to be optimistic , experts have cautioned that the data from the trials conducted by Pfizer and Bio NTech are not final , and there remain plenty of unknowns . 
Here the Guardian â€™s science correspondent Natalie Grover answers six key questions about the vaccine : 
